Five Elements
Five Elements, licence 80105642: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Five Elements (Arthritis Complex)
- Licence holder
- Global Cosmeceuticals Corp.
- NPN or DIN-HM
- 80105642
- Status
- Active licence
- Licence date
- 24 October 2020
- Revision date
- 1 March 2021
- Form
- Comprimé, à croquer
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Glucosamine Sulfate sodium Chloride | 375.0 mg | Not calculated |
| Acide hyaluronique Source : Acide hyaluronique | 30.0 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 30.0 mg | Not calculated |
| Sulfate de chondroïtine Source : Chondroïtin sulfate de sodium | 250.0 mg | Not calculated |
| Sulfate de chondroïtine Source : Cartilage | 250.0 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 20.0 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 200.0 UI | Not calculated |
| Vitamine D Source : Cholécalciférol | 5.0 microgram | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 550.0 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Povidone K-30, Maltodextrine, Carboxyméthyl amidon de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Comprimé | 2.0 Jour |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support joint health. Helps protect against the deterioration of cartilage and relieve joint pain associated with osteoarthritis. Helps to relieve (joint) pain associated with osteoarthritis (of the knee). As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80105642
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.